Acasti Pharma (ACST) Swings to Q3 Profit
Tweet
Share
E-mailGet Alerts ACST Hot Sheet
Join SI Premium – FREE
Acasti Pharma (NASDAQ: ACST) reported Q3 EPS of $0.03, versus ($0.05) reported last year. Revenue for the quarter came in at $29 million, versus $28 million reported last year.
For earnings history and earnings-related data on Acasti Pharma (ACST) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Tesla to launch Cybercab in Austin this month - report
- Wendy's U.S. president to resign, company to create COO role
- Aon names interim CFO as Edmund Reese exits the firm
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
